WuXi Biologics spinning off WuXi XDC
WuXi Biologics is an international CRDMO in the field of biopharmaceutics. It has recently proposed a spin-off of its crown jewel, WuXi XDC.
Latest
Trip review of Sydney: The quay to the city
Vivid Sydney Festival gave us a reason to visit the cosmopolitan city and we found that there are still much the city has to offer despite it not being beach season.
Budweiser APAC: Twin growth engines from China and India
What is most compelling is the fact that Budweiser APAC participates in both China and India, the twin growth engines in Asia. China may dominate the headline for now, but India is rapidly catching up to be a substantial market.
M3: Medicine, Media, Metamorphosis
We believe that M3 sits at the intersection of the medical and digitalization software industry.
Tough times for Singapore offshore REITs
With the increase in interest rates globally, cracks are starting to surface in commercial real estate. Real Estate Investment Trusts (REITs) have been key to Singapore’s capital markets, and in the last couple of years, there have been more REITs seeking overseas assets. A result of this trend is
L'Oreal to fuel Aesop expansion in China
Sitting in L’Oreal Luxe portfolio, the brand positioning looks set to fuel the next phase of growth for Aesop into a billion-dollar-sales business. Entry into China and travel retail is likely going to be a cornerstone of the strategy.
Trip review of Taipei: Flowers and hot spring
Given the proximity of Yangmingshan National Park to the Beitou District, we combined the flower chase with a local hot spring experience.